Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of ...
Dr. Reddy’s Laboratories has unveiled Methylprednisolone Sodium Succinate for Injection, USP, its generic equivalent of Solu-Medrol, in the U.S. market. The product, launched following the U.S. Food ...